Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial - Laza-Briviesca, R; Cruz-Bermúdez, A; Nadal, E (Clin Transl Med, 2021)
et al.